Open transcatheter tricuspid balloon expandable valve-in-valve implantation for failed bioprosthesis Gino Gerosa, MD, Augusto D'Onofrio, MD, Chiara Tessari, MD, Demetrio Pittarello, MD, Maurizio Rubino, MD, Andrea Colli, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 146, Issue 1, Pages e3-e5 (July 2013) DOI: 10.1016/j.jtcvs.2013.03.034 Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions
Figure 1 Surgical field. Open transcatheter tricuspid balloon expandable valve-in-valve implantation for failed bioprosthesis. A, Position of the Edwards Sapien XT valve 29 mm crimped on the balloon of the transcatheter delivery system (Ascendra; Edwards Lifesciences, Irvine, Calif) through the failed tricuspid bioprosthesis. B, Balloon inflation and valve positioning. C, Final result of valve-in-valve position. The Journal of Thoracic and Cardiovascular Surgery 2013 146, e3-e5DOI: (10.1016/j.jtcvs.2013.03.034) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions
Figure 2 Live 3-dimensional transesophageal echocardiography. A, Adequate opening of the tricuspid valve-in-valve bioprosthesis. B, Adequate closure of the tricuspid valve-in-valve bioprosthesis. C, Color Doppler showing adequate position and function of the tricuspid valve-in-valve bioprosthesis without paravalvular leaks. D, Postprocedure pulsatile Doppler of the tricuspid valve-in-valve bioprosthesis confirming a normal hemodynamic pattern. The Journal of Thoracic and Cardiovascular Surgery 2013 146, e3-e5DOI: (10.1016/j.jtcvs.2013.03.034) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions